Advertisement
Singapore markets open in 10 minutes

  • Straits Times Index

    3,330.09
    +11.64 (+0.35%)
     

  • S&P 500

    5,306.04
    +1.32 (+0.02%)
     

  • Dow

    38,852.86
    -216.74 (-0.55%)
     

  • Nasdaq

    17,019.88
    +99.08 (+0.59%)
     

  • Bitcoin USD

    68,442.17
    -763.12 (-1.10%)
     

  • CMC Crypto 200

    1,482.41
    -14.05 (-0.94%)
     

  • FTSE 100

    8,254.18
    -63.41 (-0.76%)
     

  • Gold

    2,359.00
    +2.50 (+0.11%)
     

  • Crude Oil

    80.16
    +0.33 (+0.41%)
     

  • 10-Yr Bond

    4.5420
    +0.0750 (+1.68%)
     

  • Nikkei

    39,111.01
    +255.64 (+0.66%)
     

  • Hang Seng

    18,821.16
    -6.14 (-0.03%)
     

  • FTSE Bursa Malaysia

    1,615.82
    -2.45 (-0.15%)
     

  • Jakarta Composite Index

    7,253.63
    +77.21 (+1.08%)
     

  • PSE Index

    6,501.34
    -70.26 (-1.07%)
     

Sanofi to publish COVID-19 vaccine price in development with GSK after Phase I/II trial results

Reuters
FILE PHOTO: A Sanofi logo is seen during the company's annual results news conference in Paris, France

PARIS (Reuters) - French drug maker Sanofi will announce the price of the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline after it has released Phase I/II results of the trials, vaccines chief Thomas Triomphe said on Thursday.

The company is expected to release the results from the Phase I/II clinical trials this month.

It is also developing a vaccine with U.S. biotech firm Translate Bio, with clinical human trials expected to start this month.

(Reporting by Matthias Blamont in Paris; Writing by Josephine Mason in London; Editing by Jon Boyle)